by marketing | Jul 27, 2016 | Incentive Compensation Management, MBO
PUNE, India – July 28, 2016 – PRLog — Aurochs software launches its Objectives Management solution- a self-service module that helps pharmaceutical companies to efficiently administer management based objectives. With the evolution of sales roles and...
by Amit Jain | May 29, 2016 | Incentive Compensation Management, Sales Performance Management, What-if calculator
The primary purpose of an incentive compensation (IC) plan is to act as a strategic tool to align salesperson behaviour with strategic business objectives. It acts as a catalyst to motivate the salesforce and retain top performers. Clear communication and presentation...
by Amit Jain | Mar 3, 2016 | Incentive Compensation Management, Sales Compensation Management, Sales Performance Management
Focus on Sales Incentives? Sales Incentive compensation is one of the most well-funded functions in an organization driven by sales. The way performance is incentivized is the key factor that affects the motivation levels of the sales representatives of a company and...
by marketing | Nov 30, 2015 | Incentive Compensation Management, Marketing, Sales Compensation Management, Sales Performance Management
Dec. 01, 2014 – PUNE, India — Jason Bryant (LinkedIn profile), an expert with 20 years of experience in pharmaceutical domain practice areas like sales force effectiveness, business intelligence, analytics, CRM and marketing planning, has joined the...
by Amit Jain | Sep 7, 2015 | Incentive Compensation, Incentive Compensation Business Case, Incentive Compensation Management
Many small and medium sized pharmaceutical companies still rely on Excel spreadsheets or home-grown script based solutions to manage sales incentive calculations for their salesforce. These solutions are generally preferred because of in-house resources’ familiarity...
by Amit Jain | Aug 24, 2015 | Audit and Compliance, Incentive Compensation, Incentive Compensation Management
One of the major concerns we have heard in our recent discussions with many pharmaceutical companies is managing the risk of being non-compliant with the process and financial audits. The US Sarbanes-Oxley Act (SOX) requires companies to establish and adhere to...
